Farmaforum 2024

26 Sept 2024 | Madrid, Spain

ServiceUpdated on 2 September 2024

Bioanalysis of Small Molecules & Generics

Xavier Martínez

Business Developer Iberia at KYMOS, S.L.U.

Barcelona, Spain

About

We are a GLP-certified and GCP compliant multinational CRO with broad experience working with large generics companies in need of full bioequivalence studies and small biotech innovators carrying out basic R&D. We also work with animal health firms to carry out residue depletion studies. Our experienced bioanalysis of small molecules team can support you in these specialist areas:

• Preclinical studies of small molecules
     • PK (pharmacokinetics) and PD (pharmacodynamic) calculations and statistics
     • Metabolite identification and quantification
     • Toxicokinetics
     • Biomarkers/Pharmacodynamics
• Clinical studies of small molecules
     • Phase I-IV pharmacokinetics including first-in-man dose escalation studies
     • Drug-drug interaction studies
     • Biomarkers/Pharmacodynamics
     • Bioequivalence studies of generics
• Percutaneous absorption
• Residue depletion studies
• Absorption studies

Similar opportunities